Hansoh Pharma
Company
Hansoh Pharma develops one asset, in phase 2 (obuprazine in schizophrenia). Mostly small molecule.
- 1
- Asset
- Furthest stage
- Phase 2
- 0
- Trials
- 2
- Signals
Pipeline
1Phase 2, Small molecule, schizophrenia, Partner
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Signals2
- Similar companies6